110(3): p
Understanding what happened to Amino Asylum The Regulatory Landscape That Led to These Shutdowns Understanding what happened to Amino Asylum and to the broader research peptide market in 20252026 requires understanding the regulatory environment that triggered these enforcement actions
Medication Adherence While medication adherence factors into outcomes associated with most all drugs, it is especially important with GLP1 receptor agonists, as significant weight gain frequently occurs after discontinuation of the drug
Case Example: A patient with chronic Lyme disease experienced marked improvements in fatigue and brain fog using a combination of Plaquex, Lipoic Acid, and Glutathione IVs
Monday, July 20, 2009 GLP-1 is a gut hormone released from intestinal L-cells in response to food intake
At 1 mg/mL, 100 units equals just 1 mg, a moderate dose within normal protocols